|1.||Centers for Disease Control and Prevention (CDC): 2 articles (10/2013 - 12/2012)|
|2.||Saliki, Jeremiah T: 2 articles (02/2013 - 06/2003)|
|3.||Erskine, Ronald J: 2 articles (01/2011 - 10/2007)|
|4.||Bartlett, Paul C: 2 articles (01/2011 - 10/2007)|
|5.||Morens, David M: 2 articles (12/2010 - 10/2008)|
|6.||Roth, James A: 2 articles (07/2010 - 07/2004)|
|7.||Wallecha, Anu: 2 articles (07/2010 - 09/2008)|
|8.||Rivera, Sandra: 2 articles (07/2010 - 09/2008)|
|9.||Shahabi, Vafa: 2 articles (07/2010 - 09/2008)|
|10.||Callister, Steven M: 2 articles (05/2010 - 02/2009)|
06/01/2004 - "[Efficacy of sublingual polyvalent bacterial vaccine (Lantigen B) in children with recurrent respiratory infection: a randomized double-blind controlled clinical trial]."
01/01/2002 - "Use of a C6 ELISA test to evaluate the efficacy of a whole-cell bacterin for the prevention of naturally transmitted canine Borrelia burgdorferi infection."
10/01/1994 - "Evaluation of the efficacy of a bacterin against Salmonella enteritidis infection and the effect of stress after vaccination."
09/01/1986 - "The protection against lethal H pleuropneumoniae infections in swine that was provided by vaccination with the E coli J5 and the H pleuropneumoniae bacterin appeared to be immunologically distinct on the basis of serologic analysis, indicating the possibility of different mechanisms of protection."
10/01/1984 - "Vaccination of broilers, however, is not yet feasible, Bacterin offers minimal protection against infection. "
01/18/2000 - "hyopneumoniae bacterin eliminated this benefit and the amount of pneumonia induced by PRRSV increased. "
07/01/1989 - "Efficacy of a commercial bacterin in protecting strain 13 guineapigs against Bordetella bronchiseptica pneumonia."
06/01/1988 - "The efficacy of a killed whole-cell Haemophilus somnus bacterin against induced H somnus pneumonia was examined in 10-week-old male calves. "
07/01/1987 - "To evaluate the efficacy of a commercial bacterial vaccine in protecting Strain 13 guineapigs against fatal Bordetella bronchiseptica pneumonia, it was necessary to establish the infectivity and disease pathogenesis induced by virulent organisms. "
01/18/2000 - "hyopneumoniae bacterin decreased the potentiation of PRRSV-induced pneumonia observed in the dual infected pigs. "
01/01/1992 - "Efficacy of an Escherichia coli (O111:B4) J5 bacterin for preventing naturally occurring IMI and clinical mastitis was tested in a 2.5-yr field trial in a 225-cow commercial herd. "
08/01/2014 - "This investigation evaluated the efficacy of a bacterin in reducing the prevalence of staphylococcal mastitis and somatic cell counts (SCC) in a dairy goat herd. "
04/15/2010 - "Study of the humoral immunological response after vaccination with a Staphylococcus aureus biofilm-embedded bacterin in dairy cows: possible role of the exopolysaccharide specific antibody production in the protection from Staphylococcus aureus induced mastitis."
08/01/1994 - "The objective of this study was to test the hypothesis that the incidence and severity of clinical coliform mastitis could be decreased by Re-17 mutant Salmonella typhimurium bacterin toxoid. "
02/01/1992 - "An Escherichia coli (O111:B4) J5 bacterin was tested for efficacy in reducing IMI and severity of clinical coliform mastitis in an experimental challenge trial. "
|4.||Salmonella Infections (Salmonellosis)
09/01/1978 - "Protection against salmonellosis was correspondingly reduced when the bacterin was diluted 1:10 and 1:100. "
06/01/2002 - "Additions to the herd and the presence of animals that had not received an Escherichia coli bacterin-toxoid were risk factors for salmonellosis. "
05/01/2001 - "In contrast to Salmonella infection, bacterin vaccination stimulated a weak response to Salmonella porin. "
05/01/2001 - "Salmonella infection and Salmonella bacterin vaccination are likely to stimulate different T-cell subtypes. "
05/01/2001 - "The objective of this study was to determine whether there are differences in the isotype response of cattle to Salmonella antigens following Salmonella infection and Salmonella bacterin vaccination. "
06/01/2006 - "A masked, controlled study was designed to investigate the clinical efficacy of a staphylococcal autogenous bacterin for the control of canine idiopathic recurrent pyoderma (IRP). "
06/01/2006 - "Masked, controlled study to investigate the efficacy of a Staphylococcus intermedius autogenous bacterin for the control of canine idiopathic recurrent superficial pyoderma."
04/01/1990 - "Twenty-one dogs with idiopathic superficial recurrent pyoderma were entered into a double-blind, placebo-controlled study to evaluate the efficacy of a commercial staphylococcal bacterin. "
07/01/2010 - "[Therapeutic bacterial vaccine Immunovac in complex treatment of patients with chronic pyoderma]."
04/01/1990 - "Evaluation of a commercial staphylococcal bacterin for management of idiopathic recurrent superficial pyoderma in dogs."
|10.||DNA (Deoxyribonucleic Acid)
|2.||Heterologous Transplantation (Xenotransplantation)